Relationships between binding affinities and functional potencies of several 5-HT2 receptor antagonists

Pharmacometrics

Volumn 62, Issue 5-6, 2002, Pages 97-103

  Rashid, Mamunur ^a   Ozaki, Masanobu ^a   Nagatomo, Takafumi ^a  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

Author keywords

5 HT2 antagonists; Binding affinities; Correlation study; Functional potencies

Indexed keywords

CYPROHEPTADINE; KETANSERIN; METHYSERGIDE; MIANSERIN; RITANSERIN; SARPOGRELATE; SEROTONIN 2 ANTAGONIST;

ANIMAL CELL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; BINDING AFFINITY; BINDING SITE; BRAIN CORTEX; CHEMICAL STRUCTURE; CONTROLLED STUDY; CORONARY ARTERY; CORRELATION ANALYSIS; DRUG POTENCY; DRUG RECEPTOR BINDING; FRONTAL CORTEX; INHIBITION KINETICS; MEMBRANE BINDING; MUSCLE CONTRACTION; NONHUMAN; RABBIT; RAT; RECEPTOR BLOCKING; SEROTONIN RELEASE; STRUCTURE ACTIVITY RELATION; SWINE; THROMBOCYTE; VASCULAR SMOOTH MUSCLE;

EID: 0036710898     PISSN: 03008533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bradford, M. (1976): A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 72, 23422-23426.
2. Bradley, P.B., Engle, G., Feniuk, W., Fozard, J.R., Humphrey, P.P.A., Mlddlemis, D.N., Lecharane, E.J., Richardson, B. P. and Saxena, P.R. (1986): Proposals for classification and nomenclature of functional receptors of 5-hydroxytryptamine, Neuropharmacology, 25, 563-576.
3. 2 receptors mediating contraction in vascular smooth muscle, J. Pharmacol. Exp. Ther., 218, 421-425.
4. Conn, P.J. and Sanders-Bush, E., (1987): Central serotonin receptors: Effector system, physiological roles and regulation, Pharmacology, 92, 267-277.
5. 2 receptor sites on human blood platelets, Biochem. Pharmacol., 33, 2807-2811.
6. Feniuk, W. (1984): An analysis of 5-hydroxytryptamine receptors mediating contraction of isolated smooth muscle, Neuropharmacology, 23, 1467-1472.
7. Glennon, R.A. (1990): Serotonin receptors: Clinical implications, Neurosci. Biobehav. Rev., 14, 35-47.
8. 2 antagonist, sarpogrelate hydrochloride, shows inhibitory effects on both contraction and relaxation mediated by 5-HT receptor subtypes in porcine coronary arteries, Pharmacol, 61, 263-268.
9. Holmsen, H. (1985): Platelet activation and serotonin. In: Vanhoutte, P.M. (eds), Serotonin and the Cardiovascular System, Raven press, New York, 75-86.
10. 1-adrenoceptor antagonist when compared to other β-blockers, Biol. Pharm. Bull., 18, 1066-1071.
11. Hoyer, D. and Martin, G. (1997): 5-HT receptor classification and nomenclature: Towards a harmonization with the human genome, Neuropharmacol, 36, 419-428.
12. Ichida, S., Hayashi, T. and Terao, M. (1983): Selective inhibition by ketanserin and spiroperidol of 5-HT-induced myometrial contraction, Eur. J. Pharmacol., 96, 155-158.
13. 2-serotonergic antagonists, J. Cardiovasc. Pharmacol., 7 (suppl. 7), S2-S11.
14. Leysen, J.E. (1984a): Problems in in vitro receptor binding studies and identification and role of serotonin receptor sites, Neuropharmacology, 23, 247-254.
15. Leysen, J.E., De Chaffoy De Courcelles, D., De Clerck, F., Niemegeers, C.J.E., and Van Nueten, J.M. (1984b): Serotonin-S2 receptor binding sites and functional correlates, Neuropharmacology, 23, 1493-1501.
16. Maruyama, K., Kinami, J., Sugita, Y., Takada, Y., Sugiyama, E., Tsuchihashi, H. and Nagatomo, T. (1991): MCI-9042: High affinity for serotonergic receptors as assessed by radioligand binding assay, J Pharmacobio-Dyn, 14, 177-181.
17. 2) receptors in dog brain and aorta, Chem. Phar. Bull., 36, 3113-3118.
18. Pazos, A., Cortes, R. and Palacios, J.M. (1985): Quantitative autoradiographic mapping of serotonin receptor in the rat brain II. Serotonin-2 receptors, Brain Res., 346, 231-249.
19. Peroutka, S.J., Ed. Serotonin Receptor Subtypes, Wiley-Liss, New York, 1991.
20. 3H]ketanserin recognition sites in rat striatum, J. Neurochem., 49, 1833-1838.
21. 3H]ketanserin for serotonin-2 receptor in the rabbit platelet, J Pharmacobio-Dyn., 14, 461-466.
22. 2 serotonergic receptor, J. Pharmacol. Exp. Ther., 218, 217-230.
23. Wilkinson, L.O., Dourish, C.T. in S.J. Peroutka (Ed.) (1991): Serotonin Receptor Subtypes: Basic and Clinical Aspects. Wiley, New York, pp. 147-210.
24. Wikstrom, H. and Svensson, K. (1989): Advances in central serotonergics, Annu. Rep. Med. Chem., 25, 41-25.
25. Zifa, E. and Fillon, G. (1992): Hydroxy tryptamine receptors, Pharmacol. Re., 44, 401-458.